Sami Anttila

1.6k total citations
27 papers, 1.1k citations indexed

About

Sami Anttila is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, Sami Anttila has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Sami Anttila's work include Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (8 papers) and Treatment of Major Depression (8 papers). Sami Anttila is often cited by papers focused on Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (8 papers) and Treatment of Major Depression (8 papers). Sami Anttila collaborates with scholars based in Finland, Japan and United States. Sami Anttila's co-authors include Esa Leìnonen, Terho Lehtimäki, Olli Kampman, Ari Illi, Kari M. Mattila, Martti Huuhka, Riikka Rontu, Nina Mononen, Kaija Huuhka and Merja Viikki and has published in prestigious journals such as Neuroreport, Psychiatry Research and Neuroscience Letters.

In The Last Decade

Sami Anttila

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sami Anttila Finland 18 411 269 229 214 156 27 1.1k
Ari Illi Finland 23 379 0.9× 190 0.7× 281 1.2× 236 1.1× 165 1.1× 39 1.1k
Chen‐Jee Hong Taiwan 20 242 0.6× 174 0.6× 292 1.3× 263 1.2× 192 1.2× 44 1.0k
Galila Agam Israel 22 438 1.1× 154 0.6× 270 1.2× 370 1.7× 162 1.0× 49 1.2k
Nobutaka Motohashi Japan 19 359 0.9× 205 0.8× 322 1.4× 342 1.6× 182 1.2× 58 1.2k
Se Hyun Kim South Korea 19 518 1.3× 142 0.5× 133 0.6× 313 1.5× 132 0.8× 76 1.0k
RAFAEL TEIXEIRA DE SOUSA Brazil 21 544 1.3× 209 0.8× 195 0.9× 171 0.8× 433 2.8× 45 1.1k
Yoshiteru Takekita Japan 16 321 0.8× 239 0.9× 201 0.9× 211 1.0× 157 1.0× 48 845
Jeffrey Kraft United States 9 247 0.6× 301 1.1× 317 1.4× 262 1.2× 250 1.6× 13 987
Rosa Catalán Spain 16 283 0.7× 258 1.0× 281 1.2× 209 1.0× 182 1.2× 29 866
L. Bjerkenstedt Sweden 23 713 1.7× 199 0.7× 461 2.0× 355 1.7× 282 1.8× 50 1.4k

Countries citing papers authored by Sami Anttila

Since Specialization
Citations

This map shows the geographic impact of Sami Anttila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sami Anttila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sami Anttila more than expected).

Fields of papers citing papers by Sami Anttila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sami Anttila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sami Anttila. The network helps show where Sami Anttila may publish in the future.

Co-authorship network of co-authors of Sami Anttila

This figure shows the co-authorship network connecting the top 25 collaborators of Sami Anttila. A scholar is included among the top collaborators of Sami Anttila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sami Anttila. Sami Anttila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viikki, Merja, Olli Kampman, Sami Anttila, et al.. (2011). P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. Neuroscience Letters. 493(3). 127–130. 37 indexed citations
2.
Viikki, Merja, Sami Anttila, Olli Kampman, et al.. (2010). Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neuroscience Letters. 477(3). 105–108. 62 indexed citations
3.
Kampman, Olli, Martti Huuhka, Sami Anttila, et al.. (2009). ACE polymorphism and response to electroconvulsive therapy in major depression. Neuroscience Letters. 458(3). 122–125. 17 indexed citations
4.
Viikki, Merja, Olli Kampman, Ari Illi, et al.. (2009). TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neuroscience Letters. 468(1). 80–84. 31 indexed citations
5.
Anttila, Sami, Merja Viikki, Kaija Huuhka, et al.. (2009). TPH2 polymorphisms may modify clinical picture in treatment-resistant depression. Neuroscience Letters. 464(1). 43–46. 25 indexed citations
6.
Huuhka, Kaija, Olli Kampman, Sami Anttila, et al.. (2008). RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder. Neuroscience Letters. 437(1). 25–28. 13 indexed citations
7.
Huuhka, Kaija, Sami Anttila, Martti Huuhka, et al.. (2008). Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neuroscience Letters. 448(1). 79–83. 40 indexed citations
8.
Anttila, Sami, Kaija Huuhka, Martti Huuhka, et al.. (2007). Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy. The Pharmacogenomics Journal. 8(2). 113–116. 25 indexed citations
9.
Anttila, Sami, Olli Kampman, Ari Illi, et al.. (2007). Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach. BMC Psychiatry. 7(1). 22–22. 35 indexed citations
10.
Katila, Heikki, Olli Kampman, Sami Anttila, et al.. (2006). Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia. Neuroscience Letters. 407(3). 195–198. 31 indexed citations
11.
Huuhka, Martti, Sami Anttila, Esa Leìnonen, et al.. (2005). The Apolipoprotein E Polymorphism Is Not Associated With Response to Electroconvulsive Therapy in Major Depressive Disorder. Journal of Ect. 21(1). 7–11. 17 indexed citations
12.
Leìnonen, Esa, Sami Anttila, Olli Kampman, & Ari Illi. (2005). [Is antipsychotic drug therapy predictable?].. PubMed. 121(1). 45–52. 1 indexed citations
13.
Kampman, Olli, Sami Anttila, Ari Illi, et al.. (2004). Neuregulin genotype and medication response in Finnish patients with schizophrenia. Neuroreport. 15(16). 2517–2520. 46 indexed citations
14.
Anttila, Sami, Ari Illi, Olli Kampman, et al.. (2004). Association of EGF polymorphism with schizophrenia in Finnish men. Neuroreport. 15(7). 1215–1218. 37 indexed citations
15.
Kampman, Olli, Sami Anttila, Ari Illi, et al.. (2004). Apolipoprotein E polymorphism is associated with age of onset in schizophrenia. Journal of Human Genetics. 49(7). 355–359. 27 indexed citations
16.
17.
Illi, Ari, Olli Kampman, Sami Anttila, et al.. (2003). Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics. European Neuropsychopharmacology. 13(3). 147–151. 33 indexed citations
18.
Kampman, Olli, Sami Anttila, Ari Illi, et al.. (2003). Dopamine receptor D2 −141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia. Psychiatry Research. 121(1). 89–92. 12 indexed citations
19.
Anttila, Sami, Olli Kampman, Ari Illi, et al.. (2003). NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia. Psychiatric Genetics. 13(2). 61–63. 26 indexed citations
20.
Anttila, Sami & Esa Leìnonen. (2001). A Review of the Pharmacological and Clinical Profile of Mirtazapine. CNS Drug Reviews. 7(3). 249–264. 426 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ari Illi Breakdown of academic impact, for papers by Chen‐Jee Hong Breakdown of academic impact, for papers by Galila Agam Breakdown of academic impact, for papers by Nobutaka Motohashi Breakdown of academic impact, for papers by Se Hyun Kim Breakdown of academic impact, for papers by RAFAEL TEIXEIRA DE SOUSA Breakdown of academic impact, for papers by Yoshiteru Takekita Breakdown of academic impact, for papers by Jeffrey Kraft Breakdown of academic impact, for papers by Rosa Catalán Breakdown of academic impact, for papers by L. Bjerkenstedt
Rankless by CCL
2026